Global Amniotic Membrane Market By Product (Cryopreserved and Dehydrated), By Application (Surgical Wounds, Ophthalmology and Other Applications), By End-Use ( Hospitals Ambulatory Surgical Centers (ASCs), Specialty Clinics and Research and Academic Institutes) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Market Overview

The Global Amniotic Membrane Market size is expected to be worth around USD 12.7 Billion by 2033 from USD 3.9 Billion in 2023, growing at a CAGR of 12.5 % during the forecast period from 2024 to 2033.

The amnion Membrane is widely used to heal wounds due to its bacteriostatic, pain reduction, and other properties. In recent times, the demand for tissue-based products has increased due to an increase in transplants. This has led to an increase in the number and quality of donated tissue, which is fueling the market growth.

Amniotic cells are commonly used in a variety of indications, including the reconstruction of the conjunctiva’s surface, pterygium extractions, surgical wounds (corneal ulcers), pressure and venous leg injuries, and limbal stem cell deficiencies, and regenerative medicines.

The amniotic membrane market has been witnessing significant growth in recent years, owing to the increasing demand for amniotic products in the healthcare industry. The amniotic membrane market share is currently dominated by the United States, followed by Europe and Asia-Pacific regions. The amniotic membrane market trends suggest that the use of amniotic products is rapidly gaining popularity due to their regenerative properties, making them an ideal choice for wound healing and tissue repair applications.

*Actual Numbers Might Vary In The Final Report

Key Takeaways

• Market Size & Growth: Amniotic Membrane Market size is expected to be worth around USD 12.7 Billion by 2033 from USD 3.9 Billion in 2023.
• Product Analysis: Cryopreserved Amniotic Membrane accounted for the highest revenue share at more than 57% in 2023.
• Application Analysis: surgical wounds segment was responsible for more than 40.2% of the total revenue in 2023
• End-Use Analysis: In 2023 the hospital segment held the largest share, with 39.5% more.
• Regional Analysis: North America was the dominant market, accounting for more than 35.2% of the total revenue in 2023 and holding a USD 1.4 billion value for the Amniotic Membrane Market
• Key Trends: Development of new amniotic membrane-based products for various applications and Increasing adoption of amniotic membrane products in emerging economies.
• Key Opportunities: Development of novel amniotic membrane-based therapies for regenerative medicine.Expansion of the market into new applications, such as cosmetics and dentistry

Product Analysis

Dehydrated and cryopreserved amniotic Membrane markets can be classified based on their product. Cryopreserved Amniotic Membrane accounted for the highest revenue share at more than 57% in 2023. Its high effectiveness and widespread adoption rate worldwide made it the most popular. This type of cryopreserved amniotic membrane is stored in a cell medium that contains 50% glucose at a temperature of -80 °C. The amniotic cell membrane is preserved in cryopreserved membranes. It retains its biological and histological characteristics.

The cryopreserved membranes have a major role in visual surgery. They are effective in reducing inflammation and improving recovery. This segment is expected to grow at a high growth rate in the future.

The treatment of many surgical wounds, such as reconstructions, and pressure leg ulcers, is usually done with dehydrated amniotic materials. These are typically used as biological bandages to encourage healing. Some examples of commercially-available dehydrated amniotic fluids include PalinGen (FloGraft), AmbioDisk (AmnioFix), and AmbioDisk (AmnioDisk). These membranes are popularly used to treat and manage surgical wounds. This is why dehydrated membranes are expected to increase in popularity.

Application Analysis

The market can be divided into three segments based on their application: ophthalmology and surgical wounds. In 2023, the surgical wounds segment was responsible for more than 40.2% of the total revenue. The market potential has increased due to an increase in chronic and infectious diseases. These products are used most frequently in ophthalmic surgery to speed up recovery and decrease inflammation. These membranes can also be used in reconstructive surgery to promote healing and decrease scarring.

Amniotic membranes are a great way to reduce scarring, speed up healing and lower the risk of infection. These products are in high demand due to the increase in cosmetic surgery. This has greatly aided market growth. They are also used to reconstruct burns cases, which drives their demand. These cases are ideal for amniotic membranes because they facilitate epithelialization as well as rapid wound healing.

Various factors are driving the amniotic membrane market growth, including the rising prevalence of chronic wounds and injuries, an increase in the number of surgical procedures, and the growing adoption of regenerative medicine. Moreover, advancements in the production of amniotic membrane products and their increasing applications in ophthalmology, orthopedics, and dermatology are also contributing to market expansion. Many amniotic membrane companies are investing in research and development activities to develop new and innovative products to meet the rising demand for amniotic products in the market.

It has been shown to ease pain and facilitate movement of the affected areas. This method is more affordable than xenografts or allografts. It is becoming increasingly popular in developing countries, which will accelerate market growth.

End-Use Analysis

Market segments are based on end-use and include hospitals, Ambulatory Surgical Centers (ASCs), specialist clinics, and research institutes. In 2023 the hospital segment held the largest share, with 39.5% more. This is due to patients frequenting hospitals, which are the primary care settings that allow for quick treatment for a wide variety of illnesses.

The market is expected to grow due to the increased use of amniotic cells in ASCs. These products can be used quickly and effectively, and they also allow for faster wound healing. This allows for segment growth.

Key Market Segments

Product Type

• Cryopreserved
• Dehydrated

Application

• Surgical Wounds
• Ophthalmology
• Other Applications

End-use

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Specialty Clinics
• Research And Academic Institutes

Driver

Rising Applications in Regenerative Medicine

Amniotic membrane market growth has been driven by rising interest in regenerative medicine. Thanks to its unique properties, amniotic membrane can be applied across various fields including wound healing, ophthalmology and orthopedics – it promotes tissue regeneration while decreasing inflammation making it an invaluable asset in regenerative therapies.

Trend

Expanded Adoption in Ophthalmology

Amniotic membrane market trends include an increasing adoption of amniotic membrane in ophthalmic procedures. With its ability to facilitate healing and reduce scarring, amniotic membrane has found widespread application for surgery for corneal defects and ocular surface reconstruction procedures. This trend is projected to continue due to advances in surgical techniques and greater understanding of amniotic membrane’s applications for this market.

Restraint

Limited Awareness and High Costs

Though amniotic membrane has immense potential, its use remains constrained due to limited awareness among healthcare professionals and patients, as well as high costs associated with harvesting, processing, storing, and transporting amniotic membrane. Therefore, efforts that raise awareness as well as technological innovations focused on cost reduction can help overcome such hurdles.

Opportunity

Expanding Scope of Chronic Wound Care

An emerging opportunity lies in the growing use of amniotic membrane applications for chronic wound care. Due to its ability to speed healing while limiting scarring, amniotic membrane is an attractive treatment choice for treating chronic wounds such as diabetic foot ulcers. With their prevalence continuing to increase, amniotic membrane markets stand poised to capitalize on this market opportunity with ongoing research and development initiatives.

Regional Analysis

North America dominated this market in 2023. It had accounted for the largest market share with 35.2%. Market growth in North America is due to strong healthcare infrastructure and the presence of major market players. This forecast period will see market growth continue to rise due to increased emphasis on alternative technologies as well as the adoption and promotion of advanced technologies.

Europe had the second-highest revenue share. The region is expected to grow at a steady rate from 2022 to 2032. The European region’s healthcare system, which is funded by the public, has seen a rise in product demand. Many countries have adopted universal healthcare systems. Healthcare professionals are expected to adopt amniotic skins more frequently as there is an increasing number of patients with chronic illnesses.

The WHO says that non-communicable illnesses, such as cancer, cardiovascular disease, chronic respiratory diseases, diabetes, kidney disease, and diabetes, account for 88% and 74%, respectively, of Europe’s deaths. A high number of chronic diseases and an increase in the surgical intervention are expected to drive market growth. The Asia Pacific is forecast to grow at a significant rate over the forecast period.

This region has many countries that are growing economically and have a steady increase in disposable income. This region is home to many multinational companies. It is anticipated that the growth of the market will be driven by the large unmet demand and the development of healthcare infrastructure, especially in India and Japan.

*Actual Numbers Might Vary In The Final Report

Кеу Regions and Countries

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Russia
  • Spain
  • Rest of Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Rest of Asia-Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• MEA
  • GCC
  • South Africa
  • Israel
  • Rest of MEA

Key Companies

There are many players in the market, both local and global. To ensure placental donation, the majority of market players have strong partnerships with hospitals and tissue banks. The American Association of Tissue Banks has accredited almost all of the market players to supply quality and sterile products.

The amniotic products market is highly competitive, with several players operating globally. Some of the prominent players in the market include Amnio Technology LLC, Skye Biologics Inc., IOP Ophthalmics, MiMedx Group Inc., and Osiris Therapeutics Inc. These companies are focusing on strategic collaborations and partnerships to expand their market presence and improve their product offerings.

Major market players are taking initiatives to overcome this pandemic. The market will grow rapidly over the forecast period thanks to innovative product development strategies, increased investments, partnerships, collaborations, and an increase in investment. There are two main uses for amniotic granules: as a surgical or biological graft. These membranes act as a scaffold and facilitate reepithelization when used as a graft.

In conclusion, the amniotic membrane market is expected to witness substantial growth in the coming years, with increasing demand for amniotic products in the healthcare industry, along with the rising investments by amniotic membrane companies in product innovation and development.

Key Market Players

• Alliqua BioMedical Inc.
• Amnio Technology, LLC
• Applied Biologics LLC
• Human Regenerative Technologies, LLC
• DermaSciences
• Katena Products, Inc.
• MiMedx Group Inc.
• Skye Biologics, Inc.
• Amniox Medical Inc.
• Organogensis, Inc.

Recent Developments

Clinical Applications

• Amniotic membrane has become an indispensable resource in various clinical applications, including ophthalmology, wound care and orthopedics. Recent advances may involve expanding its usage within these fields or exploring novel applications.

Research and Technology

• Advancements in biotechnology and tissue engineering may lead to the creation of innovative amniotic membrane-related technologies or products, while researchers explore ways of increasing its therapeutic properties or optimizing delivery through various medical procedures.

Regulatory Landscape

• Shifts in regulatory guidelines or approvals could have a substantial impact on amniotic membrane products’ market presence, so keep an eye out for developments within healthcare and biotechnology sectors.

Expanding Market

• Businesses operating in the amniotic membrane market may expand their product lineups or enter new geographic markets by entering strategic partnerships or collaborations to strengthen their positions.

Stem Cell Research

• Amniotic membrane contains stem cells, and research on them could aid in the creation of novel therapies and applications for amniotic membrane in regenerative medicine. Advancements could change applications of this membrane.

Report Scope